| TTM
|
7/31/2026
|
7/31/2025
|
7/31/2024
|
7/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-6,817.7290 | -6,817.7290 | -5,934.1250 | -6,152.2690 | -7,935.6260 |
|
Research and Development Expenses
|
-29,236.5080 | -29,236.5080 | -21,270.6780 | -27,177.8070 | -15,336.6380 |
| Other Income/Expense, Operating
|
-- | -- | -- | -- | 0 |
|
Operating Income/Expenses
|
-36,054.2370 | -36,054.2370 | -27,204.8030 | -33,330.0760 | -23,272.2640 |
|
Total Operating Profit/Loss
|
-36,054.2370 | -36,054.2370 | -27,204.8030 | -33,330.0760 | -23,272.2640 |
| Total Net Finance Income/Expense
|
604.1350 | 604.1350 | 82.9790 | 288.0180 | 891.2130 |
| Net Investment Income
|
124.8100 | 124.8100 | 565.6840 | 28,110.5100 | 2,078.6570 |
|
Non-Operating Income/Expenses, Total
|
728.9450 | 728.9450 | 648.6630 | 28,398.5280 | 2,969.8700 |
|
Pretax Income
|
-35,325.2920 | -35,325.2920 | -26,556.1400 | -4,931.5480 | -20,302.3940 |
|
Net Income from Continuing Operations
|
-35,325.2920 | -35,325.2920 | -26,556.1400 | -4,931.5480 | -20,302.3940 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-35,325.2920 | -35,325.2920 | -26,556.1400 | -4,931.5480 | -20,302.3940 |
|
Non-Controlling/Minority Interests
|
421.0300 | 421.0300 | 244.2730 | 140.0820 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
-34,904.2620 | -34,904.2620 | -26,311.8670 | -4,791.4660 | -20,302.3940 |
|
Net Income Available to Common Stockholders
|
-34,904.2620 | -34,904.2620 | -26,311.8670 | -4,791.4660 | -20,302.3940 |
|
Diluted Net Income Available to Common Stockholders
|
-34,904.2620 | -34,904.2620 | -26,311.8670 | -4,791.4660 | -20,302.3940 |
| Basic EPS
|
-6.97 | -6.97 | -62.19 | -43.68 | -195.00 |
| Diluted EPS
|
-6.97 | -6.97 | -62.19 | -43.68 | -195.00 |
|
Basic Weighted Average Shares Outstanding
|
5,010.9070 | 5,010.9070 | 423.1140 | 109.6990 | 104.1310 |
|
Diluted Weighted Average Shares Outstanding
|
5,010.9070 | 5,010.9070 | 423.1140 | 109.6990 | 104.1310 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-35,929.4270 | -35,929.4270 | -26,639.1190 | -5,219.5660 | -21,193.6070 |
|
EBITDA
|
-35,810.0920 | -35,810.0920 | -26,532.4920 | -5,135.6690 | -21,178.3360 |
|
Normalized EBITDA
|
-34,480.4680 | -34,480.4680 | -26,570.4500 | -31,574.0630 | -21,104.0760 |
|
Normalized Income
|
-33,995.6680 | -33,995.6680 | -26,594.0980 | -31,369.9420 | -20,228.1340 |
|
Total Unusual Items
|
1,329.6240 | 1,329.6240 | -37.9580 | -26,438.3940 | 74.2600 |
|
Total Unusual Items Excluding Goodwill
|
1,329.6240 | 1,329.6240 | -37.9580 | -26,438.3940 | 74.2600 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
7/31/2023 - 3/14/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade